TITLE

Clinicoradiological Features of Pulmonary Infarctions Mimicking Lung Cancer

AUTHOR(S)
George, C. Joseph; Tazelaar, Henry D.; Swensen, Stephen J.; Ryu, Jay H.
PUB. DATE
July 2004
SOURCE
Mayo Clinic Proceedings;Jul2004, Vol. 79 Issue 7, p895
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: to describe presenting features of pulmonary infarction that may simulate those of lung cancer. Patients and methods: We reviewed the medical records of 43 patients with pulmonary infarction diagnosed by surgical lung biopsy at the Mayo Clinic in Rochester, Minn, from January 1, 1996, to December 31, 2002. Of 16 patients presenting with an undiagnosed solitary pulmonary nodule or mass, 6 had features suggestive of lung cancer on additional imaging, including abnormalities on contrast-enhancement computed tomography (CT), position emission tomography (PET), or nonsurgical lung biopsy before surgical resection. We examined the presenting symptoms, epidemiological, clinical, and radiological features, and clinical course of these 6 patients. Results: All 6 patients, ranging in age from 41 to 85 years, had a history of smoking and underlying cardiopulmonary disease. In 5 of the 6 patients, CT showed a nodule in the subpleural region of the lung. Three patients had abnormalities on contrast-enhancement CT, 2 had abnormalities on PET, and 1 had abnormal cytologic findings on a transthoracic needle biopsy of the lung; all these studies showed abnormalities suggestive of lung cancer. Surgical resection of the nodule or mass revealed pulmonary infarction associated with organizing thrombi in all 6 patients. Conclusions: Pulmonary infarctions can closely mimic the clinicoradiological characteristics of lung cancer, an association not reported previously. Furthermore, cytologic changes that occur in pulmonary infarctions may produce malignant-appearing cells on needle biopsy of the lung. The possibility of pulmonary infarction should be considered in the differential diagnosis of a solitary lung nodule or mass located in the subpleural region, even in the absence of clinically recognized venous thromboembolism.
ACCESSION #
13838071

 

Related Articles

  • HRCT diagnosis of diffuse parenchymal lung disease: inter- observer variation. Aziz, Z. A.; Wells, A. U.; Honsell, D. M.; Bain, G. A.; Copley, S. J.; Desai, S. R.; Ellis, S. M.; Gleeson, F. V.; Grubnic, S.; Nicholson, A. G.; Padley, S. P. O.; Pointon, K. S.; Reynolds, J. H.; Robertson, R. J. H.; Rubens, M. B. // Thorax;Jun2004, Vol. 59 Issue 6, p506 

    Background: This study was designed to measure inter-observer variation between thoracic radiologists in the diagnosis of diffuse parenchymal lung disease (DPLD) using high resolution computed topography (HRCT) and to identify areas of difficulty where expertise, in the form of notional panels,...

  • Resolving small pulmonary nodules: CT features. Diederich, S.; Hansen, J.; Wormanns, D. // European Radiology;Oct2005, Vol. 15 Issue 10, p2064 

    Our aim was to analyse the CT morphology of resolving nodules over time in order seek morphologic features helpful in initial nodule classification. The imaging characteristics of 133 consecutive resolving pulmonary nodules detected in 56 subjects in a screening trial for early lung cancer with...

  • Temsirolimus.  // Reactions Weekly;11/18/2006, Issue 1128, p18 

    The article presents the cases of patients who developed pneumonitis during treatment with temsirolimus. The patients received temsirolimus for neuroendocrine tumours or endometrial cancer. The treatment was discontinued for four patients and one of them received itraconazole. They all showed...

  • Progress in the treatment of colorectal cancer. Kanellos, I. // Techniques in Coloproctology;Nov2004 Supplement 1, Vol. 8, ps1 

    This article focuses on treatment of colorectal cancer which is one of the most common malignancies in the western world. In recent years significant knowledge has been acquired and applied in everyday clinical practice as far as colorectal cancer is concerned. The attempt to improve the...

  • When You Look Matters: The Effect of Assessment Schedule on Progression-Free Survival. Panageas, Katherine S.; Ben-Porat, Leah; Dickler, Maura N.; Chapman, Paul B.; Schrag, Deborah // JNCI: Journal of the National Cancer Institute;3/21/2007, Vol. 99 Issue 6, p428 

    Progression-free survival (PFS) is increasingly used as an endpoint for cancer clinical trials. Disease progression is typically assessed on the basis of radiologic testing at scheduled time points or after a fixed number of treatment cycles. The date of the radiologic evaluation at which...

  • Clinical briefs.  // New Zealand Doctor;8/29/2007, p14 

    This section offers news briefs related to clinical medicine. Randomized trials found that postmenopausal women with low sex drives benefit from treatment with low-dose testosterone. According to Greek researchers, COPD should be screened for the obstructive sleep apnea/hypopnoea syndrome...

  • Long-term recurrence of secretory breast carcinoma with metastatic sentinel lymph nodes. Tixier, Hervé; Picard, Anne; Guiu, Séverine; Coudert, Bruno; Loustalot, Catherine; Depret, Olivier; Arnould, Laurent; Cuisenier, Jean // Archives of Gynecology & Obstetrics;Mar2011, Vol. 283, p77 

    Purpose: Secretory carcinoma is a rare form of breast cancer most frequently encountered in children or young adults. Several cases have been described in adults with increased aggressiveness and a risk of metastases. Case report: We report here, in a 30-year-old woman, a case of local relapse...

  • Preoperativna hemio-radioterapija u lečenju lokalno uznapredovalog karcinoma jednjaka. Radošević-Jelić, Ljiljana; Stanković, V.; Josifovski, T.; Nikolić, V.; Popov, I.; Peško, P. // Acta Chirurgica Iugoslavica;2009, Vol. 56 Issue 4, p83 

    Preoperative or definitive chemoradiotherapy defines today the standard treatment of patients with localized or locally advanced esophageal cancer. Preliminary results of our study are presented. 46 patients with locally advanced squamous cell esophageal cancer (T3-4, N0-1, M0) were enrolled....

  • When to order a biopsy to characterise a metastatic relapse in breast cancer. Foukakis, T.; Åström, G.; Lindström, L.; Hatschek, T.; Bergh, J. // Annals of Oncology;Sep2012 Supplement 10, Vol. 23 Issue suppl_10, px349 

    Today, the diagnosis of metastatic breast cancer is usually based on radiological findings, and therapeutic decisions are made by considering the pathological characteristics and predictive markers of the primary tumour. Accumulating evidence suggests that tumour characteristics, including...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics